Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein-Barr virus-associated infectious mononucleosis

European Journal of Haematology

Volumn 89, Issue 5, 2012, Pages 417-422

  Huang, Shu Ching ^a,b   Chen, Jiann Shiuh ^b   Cheng, Chao Neng ^b   Yang, Yao Jong ^b  

^a KUO GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Albumin; Child; Epstein Barr virus; Hemophagocytic lymphohistiocytosis; Infectious mononucleosis

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CHILD; CLINICAL FEATURE; CYTOPENIA; DISEASE ASSOCIATION; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; HYPOFIBRINOGENEMIA; IMMUNOLOGICAL PROCEDURES; JAUNDICE; LABORATORY TEST; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SPLENOMEGALY;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOALBUMINEMIA; INFANT; INFECTIOUS MONONUCLEOSIS; LOGISTIC MODELS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867467364     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12006     Document Type: Article

References (34)

1. Peter J, Ray CG. Infectious mononucleosis. Pediatr Rev 1998;19:276-9.
2. Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 2004;6:1-16.
3. Griffin BE. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems. Mutat Res 2000;462:395-405.
4. Hsu WL, Yu KJ, Chien YC, et al. Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: effects of covariates on risk. Am J Epidemiol 2011;173:292-9.
5. Kimura H, Nishikawa K, Hoshino Y, Sofue A, Nishiyama Y, Morishima T. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol 2000;188:197-202.
6. Tsai MH, Hsu CY, Yen MH, Yan DC, Chiu CH, Huang YC, Lin SJ, Lin TY. Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children. J Microbiol Immunol Infect 2005;38:255-61.
7. Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 1993;82:3259-64.
8. Kikuta H. Epstein-Barr virus-associated hemophagocytic syndrome. Leuk Lymphoma 1995;16:425-9.
9. Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa S, Kuzushima K, Shibata M, Morishima T. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 1995;33:1765-8.
10. Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 2002;44:203-15.
11. Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997;89:4100-3.
12. Mizuno S, Akashi K, Ohshima K, Iwasaki H, Miyamoto T, Uchida N, Shibuya T, Harada M, Kikuchi M, Niho Y. Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood 1999;93:3494-504.
13. Morrison TE, Mauser A, Klingelhutz A, Kenney SC. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J Virol 2004;78:544-9.
14. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
15. Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996;53:111-5.
16. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002;44:259-72.
17. Domachowske JB. Infectious triggers of hemophagocytic syndrome in children. Pediatr Infect Dis J 2006;25:1067-8.
18. Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 1985;75:1011-9.
19. Kingma DW, Medeiros LJ, Barletta J, Raffeld M, Mann RB, Ambinder RF, Jaffe ES. Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 1994;18:48-61.
20. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994;144:1219-25.
21. Ramachandran B, Balasubramanian S, Abhishek N, Ravikumar KG, Ramanan AV. Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr 2011;48:31-5.
22. Markin RS, Linder J, Zuerlein K, Mroczek E, Grierson HL, Brichacek B, Purtilo DT. Hepatitis in fatal infectious mononucleosis. Gastroenterology 1987;93:1210-7.
23. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 2002;44:283-94.
24. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8.
25. Cheng CC, Chang LY, Shao PL, Lee PI, Chen JM, Lu CY, Lee CY, Huang LM. Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis. J Microbiol Immunol Infect 2007;40:216-21.
26. Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients-a postmortem clinicopathologic analysis. Crit Care Med 2004;32:1316-21.
27. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000;85:599-610.
28. Ballmer P. Causes and mechanisms of hypoalbuminemia. Clin Nutr 2001;20:271-3.
29. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007;7:814-22.
30. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis 2003;36:306-12.
31. Arico M, Janka G, Fisher A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry. Leukemia 1996;10:197-203.
32. Chen CJ, Huang YC, Jaing TH, Hung IJ, Yang CP, Chang LY, Lin TY. Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect 2004;37:157-63.
33. Lu G, Xie ZD, Zhao SY, Ye LJ, Wu RH, Liu CY, Yang S, Jin YK, Shen KL. Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases. Chin Med J 2009;122:262-6.
34. Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 2011;56:154-5.